|
For a man
newly diagnosed with prostate cancer, the most bewildering news
may the need to choose among an array of treatment options.
The principal
choices for a person whose cancer is confined to the prostate
gland, or localized, range from surgery (a prostatectomy),
to two different types of radiation therapy (external
beam radiation or brachytherapy),
or to simply monitoring the disease to see if symptoms appear
(watchful waiting).
Yet another
treatment option that uses liquid gas to freeze and kill prostate
cancer cells, cryosurgery, has shown
some promise but while no longer experimental, is still considered
an alternative therapy.
Not only is
there no one-treatment-fits-all approach that is the right choice
for all men; there also are no results available from clinical
trials that directly compare outcomes for the various treatment
options for men with similar stages of prostate cancer.
Among the
factors that the National Cancer Institute says you should consider
are:
- Is your
cancer truly confined to the prostate gland, or has it spread
to nearby-or even distant-parts of your body?
- Is it aggressive
or slow-growing?
- What is
your general health status?
- Are you
young enough so that even a slow-growing cancer might someday
pose a threat?
- Are you
healthy enough for surgery?
- Are you
willing to risk serious, lifelong side effects to possibly reduce
your chances of a cancer death?
- How important
is it for you, in your work or recreation, to maintain bladder
or bowel control?
- How important
is it to be able to have erections?
- Would you
find it too worrisome to live with an untreated cancer, too
stressful to face frequent monitoring?
Your answers
to these questions hopefully will help you as you weigh the pros
and cons of the various treatment options.
If your cancer
has advanced beyond the prostate gland, or if it recurs and spreads
to other parts of your body, radiation may be used to help to
keep the cancer in check and hormonal
therapy may slow its advance.
Another option
for advanced disease is to enroll in a clinical trial and participte
in the study of new treatments.
|